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Abstract: 
BACKGROUND: Wheezing illnesses are characterised by phenotypic 
variability, which changes with age, but few studies report on a wide age 
range of children. We studied how prevalence, severity, and triggers of 
wheeze vary throughout childhood.  
 
METHODS: We analysed data from a large population-based cohort of 
children from Leicestershire, UK, who were followed from infancy through 
late adolescence using postal questionnaires. We used generalised 
estimating equations to describe age-related changes in prevalence of any 
wheeze: episodic viral and multiple trigger wheeze; wheeze triggered by 
exercise, aeroallergens, food/drinks, laughing/crying; and of severe 
wheeze (frequent attacks, shortness of breath, sleep disturbance, 
disturbance of daily activities) from age 1 to 18 years. We analysed this in 
the entire cohort (absolute prevalence) and separately among children with 
wheeze (relative prevalence).  
 
RESULTS: This study included 7,670 children. Current wheeze was most 
common in 1-year-olds (36%) and then decreased in prevalence to reach 
17% in children aged 14-17 years. Absolute prevalence of episodic viral 
wheeze (EVW) decreased with age (from 24% to 7%), while multiple 
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trigger wheeze (MTW) remained relatively constant throughout childhood 
(8-12%). Among children with wheeze, the proportion with EVW 
decreased, and the proportion with MTW increased with age. In older 
children, wheeze triggered by exercise or aeroallergens, and wheeze 
accompanied by shortness of breath became more frequent, while wheeze 
triggered by food or laughter, and sleep disturbance decreased in 
prevalence.  
 
CONCLUSION: Knowledge of these age-related changes in wheezing illness 
is informative for health care planning and the design of future research 
projects and questionnaires.      
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ABSTRACT   
 
BACKGROUND: Wheezing illnesses are characterised by phenotypic variability, which 
changes with age, but few studies report on a wide age range of children. We studied how 
prevalence, severity, and triggers of wheeze vary throughout childhood.  
METHODS: We analysed data from a large population-based cohort of children from 
Leicestershire, UK, who were followed from infancy through late adolescence using postal 
questionnaires. We used generalised estimating equations to describe age-related changes in 
prevalence of any wheeze: episodic viral and multiple trigger wheeze; wheeze triggered by 
exercise, aeroallergens, food/drinks, laughing/crying; and of severe wheeze (frequent attacks, 
shortness of breath, sleep disturbance, disturbance of daily activities) from age 1 to 18 years. 
We analysed this in the entire cohort (absolute prevalence) and separately among children 
with wheeze (relative prevalence).  
RESULTS: This study included 7,670 children. Current wheeze was most common in 1-year-
olds (36%) and then decreased in prevalence to reach 17% in children aged 14-17 years. 
Absolute prevalence of episodic viral wheeze (EVW) decreased with age (from 24% to 7%), 
while multiple trigger wheeze (MTW) remained relatively constant throughout childhood (8-
12%). Among children with wheeze, the proportion with EVW decreased, and the proportion 
with MTW increased with age. In older children, wheeze triggered by exercise or 
aeroallergens, and wheeze accompanied by shortness of breath became more frequent, while 
wheeze triggered by food or laughter, and sleep disturbance decreased in prevalence.  
CONCLUSION: Knowledge of these age-related changes in wheezing illness is informative 
for health care planning and the design of future research projects and questionnaires.     
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INTRODUCTION 
 
The clinical characteristics of wheezing illness in children are variable and change with age.
1-4
 
Some children wheeze only during respiratory infections, a phenotype called episodic viral 
wheeze (EVW).
5
 Other children wheeze without having infections and their episodes can be 
triggered by different factors. The wheezing in these children is commonly called multiple 
trigger wheeze (MTW).
5, 6
 Trigger factors for MTW include physical exercise,
3, 7-9
 other 
activities associated with increased breathing effort (laughing or crying), contact with 
aeroallergens
7, 10, 11
 (such as pollen, house dust, or pets), and ingestion of certain food or drink 
items,
7
 which lead to wheeze through varying mechanisms (including but not restricted to 
allergies). Severity of wheezing illness has been described in terms of frequency of episodes,
3, 
7, 8, 12
 and of severity of episodes measured as sleep disturbance,
3, 9
 limitation of daily 
activities, or association with shortness of breath.
9, 12
 
 
From clinical experience, we know that absolute and relative frequency of phenotypes of 
wheeze, severity indicators, and trigger factors vary depending on the age of children. 
However, this has not been well quantified. Most studies have focused on one or two age 
groups, typically on schoolchildren who are 6-7 and 13-14 years old, as in the International 
Study on Asthma and Allergies in Childhood (ISAAC),
3, 13
 or, less often, preschool 
children.
12, 14-16
 No study to our knowledge has shown the change in the clinical picture of 
wheezing illness from the first years of life throughout childhood. This paper describes 
prevalence of wheezing illness during the entirety of childhood, from age 1 to 18 years, in a 
population-based cohort. We assessed the absolute prevalence (as a proportion of all children) 
and the relative prevalence (as a proportion of children with current wheeze) of a) the 
phenotypes EVW and MTW, b) wheeze induced by individual triggers, and c) severity 
indicators. Absolute prevalence reflects the public health perspective (how many children in 
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the general population have this type of disease), and relative prevalence describes the 
perspective of a physician (what proportion of the children visiting for wheeze has this type of 
disease).  
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METHODS 
 
Study population and study design 
We used data from a population-based childhood cohort study from the UK, the second 
Leicestershire respiratory cohort. The study was approved by the Leicestershire Health 
Authority Research Ethics Committee. Details are published elsewhere.
17
 In short, a random 
sample of children born from May 1993 to April 1997, stratified by year of birth, sex, and 
ethnic group (South Asian or White) was selected from the Leicestershire Health Authority 
Child Health Database, which is comprised of perinatal, demographic, and health-related 
information for all children resident in the area of Leicestershire. Perinatal data came from 
birth records and growth data from prospective health-visitor records. We assessed respiratory 
symptoms through postal questionnaires mailed to parents in 1998, 1999, 2001, 2003, 2006, 
and 2010. In the first survey (1998), 78% of the families (6,808/8,700) participated. In the 
following surveys, response rates were 74%, 63%, 51%, 37% and 33%, respectively (Table 
E1).
17
 In 1998 most children were 1 year old (N=4,102), 52% were boys, and 20% were of 
South Asian ethnic origin (Table 1).  
 
Questionnaires and questions on wheezing illness 
The questionnaire defined wheeze as “breathing that makes a high-pitched whistling or 
squeaking sound from the chest, not the throat.” We assessed current wheeze (wheeze 
occurring in the last 12 months) with the question from the ISAAC.
13
 In case of reported 
wheeze, we asked whether children wheezed only during or after a cold or flu, or also at times 
unassociated with these conditions, and we assessed trigger factors and aspects of severity 
(Table 2).
18
 Repeatability for questions on wheeze was very good (ĸ 0.61–0.80).
19
 We 
grouped phenotypes into episodic viral wheeze if parents reported that children wheezed only 
with colds and multiple trigger wheeze if children also wheezed apart from colds.
6, 20
 We 
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assessed these trigger factors: exercise (running or playing), aeroallergens (house dust, pollen, 
pets), food or drinks, laughing or crying or excitement. To describe severity of wheezing 
illness, we asked how many attacks the child had had in the past 12 months (defining frequent 
as ≥4 episodes),
1
 and we inquired whether wheezing was accompanied by shortness of breath, 
led to sleep disturbance (duration ≥1 week considered severe), or interfered with daily 
activities. The questionnaires were addressed to parents until the child reached 13 years 
(surveys in 1998, 1999, 2001, 2003, 2006), and directly to children from age 14 onwards 
(survey in 2010).  
 
Statistical analyses 
We included all children who participated in at least one survey (7,670 children, 88%). Due to 
the range in birth years (1993-7), children were age 1-4 years at the first survey in 1998 and 
13-17 in 2010. For this analysis, we grouped children by age, rather than by survey, into the 
following age groups: 1 year, 2 years, 3-4, 5-6, 7-9, 10-13 and 14-17 years (Fig. E1). We 
formed narrower age groups in early childhood when physiological and environmental 
changes occur faster. Children were included only once in each age group (using the survey 
when children were closest to the midpoint of that age group) but could contribute 
information to several age groups if they had participated in more than one survey. For the 
analysis we thus used information on 4,102 children aged 1 year, 3,163 children aged 2, 4,071 
aged 3-4, 4,031 aged 5-6, 3,244 aged 7-9, 2,204 aged 10-13, and 2,025 aged 14-17 years. 
 
We calculated prevalence and 95% confidence intervals (CI) of current wheeze and of 
features of wheeze (wheeze induced by different triggers, wheeze severity markers). We did 
this for each age group in the entire cohort (absolute prevalence) and in children with current 
wheeze (relative prevalence). We assessed changes in prevalence with age using logistic 
generalised estimating equation (GEE) models with an exchangeable working correlation 
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structure. These models estimate population-averaged changes in prevalence, accounting for 
repeated measurements of wheeze for children who participated in several surveys.
21
 We 
calculated odds ratios (ORs) and 95% CI for wheeze in younger and older children compared 
to the baseline group of children aged 5-6 years.  
 
In a sensitivity analysis, we assessed the potential effect of attrition bias on our results. 
Attrition bias, caused by decreasing response rates, is common in cohort studies. Since 
nonresponders might comprise a different population than responders, attrition could distort 
the results so that they are no longer representative for the entire cohort. We explored whether 
attrition bias might have affected our results by using inverse probability weight and 
comparing weighted prevalence of outcomes to unweighted prevalence. To do this, we 
modelled the probability of participation at each survey with logistic regression models by 
assessing which baseline factors were associated with participation. We used the following 
factors: age, sex, ethnicity (White, South Asian), low birth weight (<2,500 g), gestational age 
(<37 weeks), maternal age, Townsend deprivation index,
22
 living in an urban area (Leicester 
postcodes LE1-LE5), and participation in previous surveys. From these models we predicted 
individual response probabilities for different surveys and inverted them to obtain individual 
weights.
23
 In a further sensitivity analysis for those who were 14 to 17 years old, an age group 
in which we had both parent-reported and self-reported questionnaires (from the 2010 
survey), we assessed whether results differed by type of respondent. We prepared and 
analysed the data using Stata 14.0 (Stata Corporation, Austin, Texas), and R version 3.3.0.   
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RESULTS 
 
Absolute prevalence of current wheeze, phenotypes, trigger factors, and severe wheeze in the 
entire cohort 
Prevalence and features of wheeze varied significantly with age (Table 3 Panel a, Figs. 1 and 
2). Current wheeze decreased in prevalence during preschool years from 36% in 1-year-olds 
to 24% in 2-year-olds, 20% in 3-4-year-olds, and 15-17% in schoolchildren irrespective of 
age (Table 3). This differed by wheeze phenotype. Absolute prevalence of EVW decreased 
steeply with age from 24% in 1-year-olds to 5% in 7-9-year-olds with no significant changes 
thereafter (Table E2). In contrast, MTW changed little with age. It was reported for 8-12% of 
children throughout childhood, with slightly higher prevalence in 1-year-olds and 10 to 17-
year-olds compared to 5-6-year-olds (Table E2).  
Furthermore, the presence of trigger factors also was age-dependent. Wheeze with exercise 
was reported for 8-9% of children until age 9, then became more frequent, reaching 13% in 
adolescents (Table 3, Fig. 1; Table E3). Wheeze induced by aeroallergens was rare in 1-2-
year-olds (2-3%), reported more often from age 5 onwards (5%), and reached 10% in 
adolescents. Wheeze triggered by food or drinks remained rare (1-3%) throughout childhood. 
Laughing or crying was reported to trigger wheeze in 10% of 1-year-olds and 6% of 2-year-
olds, decreased in prevalence to 3% at age 3-4, and again became slightly more common in 
adolescence (6% at age 14-17).  
Severe wheeze was rare in the entire cohort and changed little with age (Table 3, Fig. 1; Table 
E4). Frequent attacks (≥4/year) were reported most often for 1-year-olds (13%); this 
decreased slowly to 5% at age 10-13. Shortness of breath together with wheeze was rare and 
reported for only 2-5% of children throughout childhood. Sleep disturbance due to wheeze 
was most frequent in infants (9%), became gradually less common, and was reported for 2% 
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of children aged 14-17. Interference of wheeze with daily activities was reported for 5% of 
infants and decreased slowly to 2% in adolescents.  
 
Relative prevalence of wheeze phenotypes, trigger factors, and severe wheeze among children 
with current wheeze 
Results looked different when viewed from a physician’s perspective as a proportion of all 
children with current wheeze (Table 3 Panel b, Figs. 2-3 and Tables E5-7). At age 1, two-
thirds of children were reported to have the phenotype EVW and one-third MTW; this 
reversed to 60% with MTW and 40% with EVW in adolescents (Fig. 2).  
The proportion of wheezing children with exercise-induced wheeze increased greatly, from 
26% in infants to 78% in adolescents; this increase in relative prevalence (Fig. 3) was much 
steeper than the increase in absolute prevalence (Fig. 1). Similarly, aeroallergens were 
reported to trigger attacks in 6% of infants and around 60% of children age 10 or older. The 
proportion of children with wheeze reporting that attacks were triggered by food or drinks (8 
to 13%) or by laughter or crying (30 to 37%) differed little between age groups.  
About one-third of children with wheeze in all age groups (37%) were reported to have 
frequent attacks (≥4/year) throughout childhood. In contrast, the proportion of current 
wheezers for whom parents reported shortness of breath increased with age from 7% at age 1 
to 26% at age 14-17 (Fig. 3). Sleep disturbance on the other hand became less important in 
older children: it was reported for 24% of 1-year-old wheezing children, but for only 11% of 
14-17-year-olds with current wheeze. Interference with daily activities was reported most 
often (20%) for 3-9-year-olds.   
  
Sensitivity analyses  
The weighted results from the sensitivity analyses that adjusted for potential attrition bias 
were very similar to those from the unweighted analysis, suggesting that the results were not 
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biased by the lower response rates (Tables E8, E9). The sensitivity analysis in 14-17-year-olds 
that compared parent-reported questions (N=749) with self-reported questions (N=1,072) 
from the 2010 survey found a mainly nonsignificant trend to lower prevalence when 
symptoms were reported by parents (Table E10). 
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DISCUSSION 
 
Wheezing illness presents with significant, age-related changes throughout entire childhood. 
While it is well known that wheezing illness changes with age, this is the first study to give a 
detailed picture from both a population perspective (absolute prevalence) and the perspective 
of a physician seeing children with current wheeze (relative prevalence). With the decline in 
episodic viral wheeze, current wheeze becomes less common with age. Multiple trigger 
wheeze remains stable across the entire cohort, but its proportion among wheezing children 
increases with increasing age. Laughing frequently triggers wheeze in younger children, 
whereas exercise and aeroallergens are more common triggers in adolescents. 
 
Strengths and limitations 
The main strengths of the study include (i) its large and representative sample from a 
population-based cohort, (ii) detailed age resolution from infancy through adolescence, (iii) 
standardised methodology, and (iv) the broad array of features studied, which include 
phenotypes, triggers, and severity. Because of attrition in later surveys, we also performed a 
weighted analysis, which showed results similar to the unweighted analysis suggesting that 
nonresponse bias did not affect our findings. A potential limitation is that symptoms were 
parent-reported. However, this reflects the reality of epidemiological surveys and clinical 
practice in which parents describe the symptoms of their children. As in other studies such as 
the ISAAC, we addressed questions to parents of younger children and directly to older 
children (from age 14 onwards). A sensitivity analysis in those aged 14-17 suggests that this 
did not affect the results much. As in most other studies,
3, 4
 we assessed symptom prevalence 
retrospectively over the last 12 months; but our questions on wheeze had a good repeatability 
when asked again 3 months later.
19
 Finally, it could be argued that age-related changes might 
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have been overlaid by temporal trends in prevalence of wheeze from 1998 to 2010. However, 
prevalence of wheezing illness in the Western world has levelled off in the last two decades.
2
 
 
Prevalence and phenotypes of wheeze 
Changes of prevalence with age have been documented rarely and only over limited age 
ranges, none covering the entire age range. However, the prevalence of wheeze we observed 
in children 6-7 and 13-14 years old appears comparable to that in reports on the same 
geographic region during the same period.
3, 4
 Current wheeze decreased from 16% in 2-year-
olds to 7% in 7-9-year-olds, in 3,963 children from the Prevention and Incidence of Asthma 
and Mite Allergy (PIAMA) birth cohort.
12
 In 370 Australian children in the Childhood 
Asthma Prevention Study (CAPS) cohort, wheeze decreased from 46% of 1-year-olds to 25% 
in 11-year-olds.
24
 Two yet earlier studies suggested a slight decrease in prevalence in 
schoolchildren from age 7 to 15.
25, 26
  
  
Regarding wheeze phenotypes, we know that the proportion of children with EVW decreases 
with age, while the proportion with MTW increases.
27-30
 What is new in this study is that we 
showed a considerable proportion of children reporting EVW throughout childhood to the 
ages of 14 to 17 years, which may indicate that EVW is not restricted to preschoolers as is 
often suggested.
6, 29, 31
 Furthermore, we found that the prevalence of MTV—although 
increasing relatively as a proportion of all children with wheeze—does not change much in 
absolute numbers throughout childhood, affecting between 8 and 12% of children at all ages. 
It has been questioned whether these phenotypes are stable over time and thus independent 
disorders.
32, 33
 However, recent data from the Leicester Respiratory Cohorts and the Avon 
Longitudinal Study of Parents and Children cohort (ALSPAC) suggest that MTW and, to a 
lesser extent, EVW track throughout childhood, independent of severity, and thus seem to be 
separate disorders.
34
 Although allergic triggers (aeroallergens) become important only in late 
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preschool years, wheeze was reported apart from colds for many infants and toddlers. Their 
symptoms in infection-free periods were not triggered by allergens, but mostly by activities 
associated with increased breathing effort (exercise, laughing, crying).   
 
Triggers and severity of wheeze  
Exercise was relevant for all age groups and was the most common trigger reported. While 
absolute prevalence of exercise-induced wheeze changed little with age (8 to 13%), its 
importance among children with wheeze increased. It affected only one-quarter of 1-year-
olds, but three-quarters of adolescents. In line with our results, an Australian study reported 
that at ages 7, 12, and 15 years, respectively 57%, 78%, and 80% of Melbourne children with 
current wheeze reported exercise as a trigger.
26
 This study also reported an age-related 
increase of aeroallergen-triggered symptoms comparable to our results, from 6% at age 7 to 
12% at age 15.
26
 This mirrors the age-related increase in sensitization to inhaled allergens and 
atopic rhinitis described in other cohorts.
35, 36
 Also, a US study in asthmatic children aged 2-
20 years showed that the impact of allergy problems and physical activity in triggering asthma 
episodes increased with increasing age.
37
 Wheeze triggered by food or drinks, which can be 
mediated via different mechanisms, has been described with a comparable prevalence (1% in 
1-5-year-olds) in the first Leicester cohort for 1,422 children born 1985-90.
7
  
 
Severity of wheeze (frequency of attacks, shortness of breath, sleep disturbance, and activity 
restriction) has been assessed in other studies,
3, 9, 12, 38
 but has rarely been compared between 
age groups. We found that the proportion of wheezing children with frequent attacks—about 
one-third—remains the same throughout childhood. The proportion of children with wheeze 
whose sleep is disturbed decreases from 24% in infants to 11% in adolescents. Shortness of 
breath increases in prevalence from 7% in infants to 26% in adolescents. This might partly be 
due to a better ability of older children to describe this symptom. Shortness of breath was 
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more frequent in some German,
38
 Dutch,
12
 and Eastern European studies
39, 40
 compared to 
ours, but their questions were not all worded exactly the same, and interpretation might differ 
between languages.  
 
Interpretation of findings  
Our results are likely influenced by several factors that all change with age, including 
physiological, developmental, and environmental factors. Physiological changes, for instance 
an increase in the absolute diameter of the airways, and also the development of the immune 
system might explain the decreasing prevalence of virus-induced wheeze during the first years 
of life, while the increasing proportion of children sensitised to aeroallergens explains the 
rising relevance of aeroallergens as triggers. With increasing cognitive abilities, children are 
better able to express subjective symptoms such as shortness of breath. Disturbed sleep might 
seem less important in older children, whose sleep is monitored less closely by parents than it 
is in early childhood. Finally, exercise becomes more competitive in later school years so that 
limitations can no longer be avoided by an adapted lifestyle, but become obvious in 
comparison to peers. Nearly 80% of adolescents with wheeze reported exercise-induced 
symptoms in our study.  
 
This study demonstrates in detail how prevalence and clinical presentation of wheeze vary 
with age and reflect fundamental immunological, physiological, and environmental changes. 
The results give a detailed picture of the burden of wheezing illness throughout childhood and 
are thus useful from a public health perspective for health-care planning. Future research 
projects can make use of the information on the trigger factors and severity indicators that are 
important for specific age groups to design their questionnaires.  
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A clear understanding of age-related patterns, including trigger factors and markers of 
severity, is essential for providing clinical care and conducting and interpreting research 
studies.   
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Table E1—Response rates for questionnaire surveys 
Year of survey Ncontacted Nreplied 
Response 
rate A 
%c 
Response 
rate B 
%d 
Age of the child when 
questionnaire was filled 
in (years) 
1998 8,700
a
 6,808 78.3 78.3 0.7 to 5.5 
1999b 3,241 2,407 74.3 -
b 1.9 to 3.2 
2001 8,225 5,212 63.4 59.9  3.9 to 8.5 
2003 8,283 4,236 51.1 48.7 5.9 to 10.2 
2006 8,233 3,028 36.7 34.8 8.3 to 13.9 
2010 7,642 2,544 33.3 29.2 13.1 to 17.9 
a After the age of 5 years, the address database was not updated, thus we did not have valid addresses for all 
children and not all 8,700 children were contacted at different surveys 
b
 Questionnaire only for a subsample, for those who were aged 1 year in 1998 and had replied to the 
questionnaire in 1998 
c
 Response rate A: number of participants who replied/ number of participants who were contacted at the 
respective survey (for instance for the 2010 survey: 2,544/7,642) 
d
 Response rate B: number of participants who replied/ number of originally sampled children (for instance for 
the 2010 survey: 2,544/8,700).  
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TABLE 1—Characteristics of the study population aged 1 year (N=4,102) 
    n (%) 
Demographic factors 
Age (years, mean[SD]) 1.5 [0.3] 
Male 2,136 (52) 
Ethnicity White 3,301 (80) 
South Asian 801 (20) 
Perinatal and early life factors 
Low birth weight (<2500g) 279 (7) 
Gestational age <37 weeks 277 (7) 
Breastfed   2,400 (58) 
Symptoms of the child 
Current wheeze 1,447 (36) 
Cough without colds  1,403 (34) 
Number of colds (in the last 12 months) 0-3 1,862 (45) 
4-6 1,457 (36) 
≥7 772 (19) 
Environmental exposures 
Nursery care 1,040 (25) 
Number of older siblings 0 1,292 (32) 
1 or 2 2,228 (54) 
≥3 381 (9) 
Pet ownership  1,662 (41) 
Mother smoking during pregnancy 688 (17) 
Mother smoking (postnatal) 889 (22) 
Father smoking 1,029 (25) 
Socioeconomic factors 
Higher parental educationa 2,350 (57) 
More deprived Townsend deprivation index
b
 610 (15) 
Parental history of atopic diseases 
Hay fever (mother or father) 1,846 (45) 
Wheeze or asthma (mother or father)   1,354 (33) 
a
 Age at the end of education is >16 years 
b
 The categories cover the following Townsend Deprivation Index intervals: more affluent 
[-6.222, -2.635], affluent [-2.615, -0.707], average [-0.705, 1.859], deprived [1.861, 5.147], 
more deprived [5.160, 11.072] 
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TABLE 2—Original questions about wheezing characteristics analysed in this study  
Question Source of the question 
Current wheeze 
Has your child had wheezing or whistling in the chest in the last 12 months? 
□ yes 
□ no 
 
International Study of 
Asthma and Allergy in 
Childhood (ISAAC)
13
 
 
If yes: 
In the last 12 months, has your child had wheezing or whistling in the chest 
during or soon after a cold or flu? 
□ yes 
□ no 
 
Adapted from American 
Thoracic Society 
questionnaires
18
 
 
In the last 12 months, has your child had wheezing or whistling in the chest even 
without having a cold or flu? 
□ yes 
□ no 
 
Adapted from American 
Thoracic Society 
questionnaires
18
 
 
In the last 12 months did the following things cause wheezing in your child? 
□ Exercise (playing, running) 
□ House dust 
□ Pollen (grass, hay, trees, flowers) 
□ Contact with pets or other animals  
□ Food or drinks 
□ Laughing, crying or excitement 
 
Adapted from the earlier 
questionnaire used in 
Leicestershire 
(Leicester Respiratory 
Cohort 1990)
17
 
 
How many attacks of wheezing has your child had during the last 12 months? 
□ None 
□ 1 to 3  
□ 4 to 12  
□ More than 12 
 
ISAAC
13
 
Do these attacks cause him/her to be short of breath? 
□ Yes, always 
□ Yes, occasionally 
□ No, never 
Verbatim earlier 
questionnaire used in 
Leicestershire (Leicester 
Respiratory Cohort 1990)
17
 
 
In the last 12 months, how often, on average, has your child’s sleep been 
disturbed due to wheezing? 
□ Never woken with wheezing 
□ Less than one night per week 
□ One or more nights per week 
 
ISAAC
13
 
In the last 12 months, how much did wheezing interfere with your child’s daily 
activities? 
□ Not at all 
□ A little 
□ A moderate amount 
□ A lot 
 
ISAAC13 
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TABLE 3—Prevalence of current wheeze, wheeze with triggers, and indicators of severe wheeze in children from age 1 to 17  
2a) Absolute prevalence: proportion of children with wheeze in entire cohort 
2b) Relative prevalence: proportion of children with certain features of wheeze among wheezers 
Age (years): 1 (N=4,102) 2 (N=3,163) 3-4 (N=4,071) 5-6 (N=4,031) 7-9 (N=3,244) 10-13 (N=2,204) 14-17 (N=2,025) 
2a) Absolute prevalence (in entire cohort) n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) 
Wheeze 1,447 36 (34-37) 744 24 (23-26) 810 20 (19-21) 675 17 (16-18) 465 15 (13-16) 362 17 (15-18) 336 17 (15-18) 
Episodic viral wheeze 955 24 (23-25) 486 16 (15-17) 445 11 (10-12) 356 9 (8-10) 173 5 (5-6) 139 6 (5-8) 122 7 (5-8) 
Multiple trigger wheeze 459 12 (11-12) 233 8 (7-9) 319 8 (7-9) 299 8 (7-8) 272 9 (8-10) 208 10 (8-11) 183 10 (8-11) 
Triggers of wheeze 
              
Exercise 331 9 (8-9) 246 8 (7-9) 306 8 (7-9) 305 8 (7-9) 266 9 (8-9) 236 11 (10-12) 255 13 (12-14) 
Aeroallergens 77 2 (2-3) 74 3 (2-3) 200 5 (5-6) 236 6 (5-7) 218 7 (6-8) 205 10 (8-11) 188 10 (8-11) 
Food/drinks 103 3 (2-3) 48 2 (1-2) 52 1 (1-2) 59 2 (1-2) 50 2 (1-2) 37 2 (1-2) 26 1 (1-2) 
Laughing/crying 383 10 (9-11) 164 6 (5-7) 112 3 (3-4) 137 4 (3-4) 76 3 (2-3) 102 5 (4-6) 118 6 (5-7) 
Indicators of severe wheeze 
              
≥4 wheezing attacks 504 13 (12-14) 258 8 (7-9) 318 8 (7-9) 249 6 (6-7) 208 7 (6-7) 116 5 (4-6) 104 5 (4-6) 
Shortness of breath due to wheeze 95 2 (2-3) 76 3 (2-3) 76 4 (3-4) 47 3 (2-4) 84 3 (2-3) 72 4 (3-4) 85 5 (4-5) 
Sleep disturbed >1/week due to wheeze 345 9 (8-10) 155 5 (4-6) 172 4 (4-5) 140 4 (3-4) 88 3 (2-3) 46 2 (2-3) 36 2 (1-3) 
Wheeze interfering moderately or a lot 
with daily activities 
185 5 (4-5) 105 3 (3-4) 155 4 (3-5) 134 4 (3-4) 92 3 (2-4) 49 2 (2-3) 39 2 (1-3) 
Age (years): 1 (N=1,447) 2 (N=744) 3-4 (N=810) 5-6 (N=675) 7-9 (N=465) 10-13 (N=362) 14-17 (N=336) 
 2b) Relative prevalence (among wheezers) N % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) 
               
Episodic viral wheeze 955 68 (65-70) 486 68 (64-71) 445 58 (55-62) 356 54 (51-58) 173 39 (34-43) 139 40 (35-45) 122 40 (35-46) 
Multiple trigger wheeze 459 33 (30-35) 233 32 (29-36) 319 42 (38-45) 299 46 (42-50) 272 61 (56-65) 208 60 (55-65) 183 60 (55-66) 
Triggers of wheeze 
           
   
Exercise 331 26 (24-28) 246 38 (34-41) 306 44 (40-48) 305 50 (46-54) 266 62 (58-67) 236 67 (62-71) 255 78 (73-82) 
Aeroallergens 77 6 (5-8) 74 12 (9-14) 200 30 (27-34) 236 39 (35-43) 218 52 (49-59) 205 58 (53-64) 188 58 (52-63) 
Food/drinks 103 8 (7-10) 48 8 (6-10) 52 8 (6-10) 59 10 (8-13) 50 13 (9-16) 37 11 (8-15) 26 8 (5-11) 
Laughing/crying 383 34 (31-37) 164 33 (28-37) 112 33 (28-38) 137 35 (31-40) 76 30 (25-36) 102 31 (26-36) 118 37 (31-42) 
Indicators of severe wheeze 
           
   
≥4 wheezing attacks 504 35 (33-38) 258 35 (32-39) 318 40 (36-43) 249 37 (34-41) 208 45 (41-50) 116 32 (27-37) 104 32 (27-37) 
Shortness of breath due to wheeze 95 7 (5-8) 76 10 (8-13) 76 17 (14-21) 47 17 (13-22) 84 19 (15-22) 72 21 (16-25) 85 26 (21-31) 
Sleep disturbed >1/week due to wheeze 345 24 (22-27) 155 21 (18-26) 172 22 (19-25) 140 21 (18-24) 88 19 (15-23) 46 13 (10-17) 36 11 (8-14) 
Wheeze interfering moderately or a lot    
    with daily activities 
185 13 (11-15) 105 14 (12-17) 155 20 (17-22) 134 20 (17-23) 92 20 (16-23) 49 14 (10-18) 39 12 (8-16) 
 
N, number of children who returned the questionnaire at the respective age 
Percentages are calculated based on those who responded to the respective questions 
All wheeze features refer to the past 12 months
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Fig. 1. Absolute prevalence of wheeze, triggered by different factors, and of different indicators of wheeze 
severity in entire cohort of children from age 1 to 17 years. Prevalence presented as proportion (in %) with 
95% confidence intervals.  
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Fig. 2. Prevalence of episodic viral wheeze and of multiple trigger wheeze in the entire cohort (absolute 
prevalence) and among children with current wheeze (relative prevalence, from age 1 to 17 years. 
Prevalence is presented as proportion (in %) with 95% confidence intervals.    
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Table E2—Age-related change in prevalence of wheeze (current, episodic viral, and multiple 
trigger) in entire cohort, presented as OR for different age groups* 
Wheeze Episodic viral wheeze Multiple trigger wheeze 
Age groups (years) OR (95% CI)  OR (95% CI)  OR (95% CI)  
1 2.7 (2.4-2.9)  3.1 (2.8-3.5)  1.5 (1.4-1.8)  
2 1.5 (1.4-1.7)  1.9 (1.6-2.1)  1.0 (0.8-1.2)  
3-4 1.2 (1.1-1.4)  1.3 (1.1-1.5)  1.1 (0.9-1.2)  
5-6 (reference) 1.0  1.0  1.0  
7-9 0.8 (0.8-0.9)  0.6 (0.5-0.7)  1.2 (1.0-1.3)  
10-13 1.0 (0.9-1.2)  0.7 (0.6-0.9)  1.4 (1.2-1.6)  
14-17 1.0 (0.9-1.2)  0.7 (0.6-0.9)  1.4 (1.2-1.7)  
*Age-related change: test for the significance of change in prevalence with age for each of the symptoms, calculated with GEE 
and presented as odds ratio of change in prevalence per age group with respective p-values, accounting for repeated nature of 
measurements and clustered data. Baseline group: 5-6-year-old children. All symptoms refer to the past 12 months. 
OR, odds ratio (GEE, generalised estimating equations, analysis) 
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Table E3—Age-related change in prevalence of wheeze with triggers in entire cohort, presented as OR,  
for different age groups* 
Exercise Aeroallergens Food/drinks Laughing/crying  
Age groups (years) OR (95% CI)  OR (95% CI)  OR (95% CI)  OR (95% CI)   
1 1.1 (0.9-1.2)  0.3 (0.2-0.4)  1.7 (1.3-2.3)  2.6 (2.2-3.1)   
2 1.0 (0.9-1.2)  0.4 (0.3-0.5)  1.1 (0.7-1.5)  1.4 (1.2-1.8)   
3-4 1.0 (0.9-1.2)  0.9 (0.7-1.0)  0.9 (0.6-1.3)  0.9 (0.7-1.1)   
5-6 (reference) 1.0  1.0  1.0  1.0   
7-9 1.1 (1.0-1.3)  1.2 (1.0-1.4)  1.0 (0.7-1.4)  0.8 (0.6-1.0)   
10-13 1.5 (1.3-1.8)  1.7 (1.4-2.0)  1.2 (0.8-1.7)  1.4 (1.1-1.8)   
14-17 1.8 (1.6-2.1)  1.7 (1.4-2.0)  0.8 (0.5-1.3)  1.8 (1.4-2.2)   
*Age-related change: test for the significance of change in prevalence with age for each of the symptoms, calculated with GEE and presented as odds ratio of change in 
prevalence per age group with respective p-values, accounting for repeated nature of measurements and clustered data. Baseline group: 5-6-year-old children. All 
symptoms refer to the past 12 months. 
OR, odds ratio (GEE, generalised estimating equations, analysis) 
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Table E4—Age-related change in prevalence of indicators of wheeze severity in entire cohort, presented as OR,  
for different age groups* 
Frequent wheeze
a Shortness of breathb Sleep disturbancec Daily activities disturbanced 
Age groups (years) OR (95% CI)  OR (95% CI)  OR (95% CI)  OR (95% CI)  
1 2.1 (1.8-2.4)  0.8 (0.6-1.1)  2.5 (2.1-3.0)  1.4 (1.1-1.7)  
2 1.4 (1.2-1.6)  0.8 (0.6-1.2)  1.4 (1.2-1.8)  1.0 (0.8-1.3)  
3-4 1.3 (1.1-1.5)  1.2 (0.8-1.7)  1.2 (1.0-1.5)  1.2 (0.9-1.4)  
5-6 (reference) 1.0   1.0   1.0   1.0  
7-9 1.0 (0.9-1.2)  1.0 (0.7-1.4)  0.8 (0.6-1.0)  0.9 (0.7-1.1)  
10-13 0.9 (0.7-1.1)  1.2 (0.8-1.7)  0.6 (0.5-0.9)  0.7 (0.5-1.0)  
14-17 0.9 (0.7-1.1)  1.6 (1.1-2.2)  0.5 (0.4-0.8)  0.6 (0.5-0.9)  
*Age-related change: test for the significance of change in prevalence with age for each of the symptoms, calculated with GEE and presented as odds ratio of change in 
prevalence per age group with respective p-values, accounting for repeated nature of measurements and clustered data. Baseline group: 5-6-year-old children.  
All symptoms refer to the past 12 months. 
a Frequent wheeze (≥4 wheeze attacks in past 12 months) 
b Wheeze always causing shortness of breath 
c Sleep disturbed due to wheeze (>1/week) 
d At least moderate disturbance of daily activities due to wheeze 
OR, odds ratio (GEE, generalised estimating equations, analysis) 
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Fig. 3. Relative prevalence of wheeze, triggered by different factors, and of different indicators of wheeze 
severity among children with current wheeze from age 1 to 17 years. Prevalence presented as proportion (in 
%) with 95% confidence intervals.  
 
338x150mm (96 x 96 DPI)  
 
 
Page 60 of 66
John Wiley & Sons, Inc.
Pediatric Pulmonology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Table E5—Age-related change in prevalence of wheeze phenotypes (episodic viral and 
multiple trigger) among children with current wheeze, presented as OR, for different 
age groups* 
Episodic viral wheeze      Multiple trigger wheeze 
Age groups (years) OR (95% CI)  OR (95% CI)  
1 1.6 (1.3-1.9)  0.6 (0.5-0.7)  
2 1.7 (1.4-2.1)  0.6 (0.5-0.7)  
3-4 1.1 (0.9-1.4)  0.9 (0.7-1.1)  
5-6 (reference) 1.0  1.0  
7-9 0.5 (0.4-0.7)  1.8 (1.4-2.3)  
10-13 0.5 (0.4-0.7)  1.8 (1.4-2.3)  
14-17 0.5 (0.4-0.7)  1.9 (1.5-2.5)  
*Age-related change: test for the significance of change in prevalence with age for each of the symptoms, calculated with GEE 
and presented as odds ratio of change in prevalence per age group with respective p-values, accounting for repeated nature of 
measurements and clustered data. Baseline group: 5-6-year-old children. All symptoms refer to the past 12 months. 
OR, odds ratio (GEE, generalised estimating equations, analysis) 
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Table E6—Age-related change in prevalence of wheeze with triggers among children with current wheeze,  
presented as OR, for different age groups* 
Exercise Aeroallergens Food/drinks Laughing/crying  
Age groups (years) OR (95% CI)  OR (95% CI)  OR (95% CI)  OR (95% CI)   
1 0.4 (0.3-0.5)  0.1 (0.1-0.2)  0.8 (0.6-1.1)  1.0 (0.8-1.3)   
2 0.6 (0.5-0.8)  0.2 (0.2-0.3)  0.8 (0.5-1.1)  1.0 (0.7-1.2)   
3-4 0.8 (0.6-1.0)  0.7 (0.6-0.9)  0.8 (0.6-1.2)  0.9 (0.7-1.2)   
5-6 (reference) 1.0  1.0  1.0  1.0   
7-9 1.6 (1.3-2.0)  1.7 (1.3-2.1)  1.1 (0.8-1.7)  0.9 (0.7-1.3)   
10-13 2.1 (1.6-2.6)  2.3 (1.8-2.9)  1.1 (0.8-1.7)  0.9 (0.7-1.2)   
14-17 3.6 (2.7-4.7)  2.4 (1.9-3.1)  0.7 (0.4-1.1)  1.2 (0.9-1.6)   
*Age-related change: test for the significance of change in prevalence with age for each of the symptoms, calculated with GEE and presented as odds ratio of change in 
prevalence per age group with respective p-values, accounting for repeated nature of measurements and clustered data. Baseline group: 5-6-year-old children. All 
symptoms refer to the past 12 months. 
OR, odds ratio (GEE, generalised estimating equations, analysis) 
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Table E7—Age-related change in prevalence of indicators of wheeze severity among children with current wheeze, 
presented as OR, for different age groups* 
Frequent wheeze
a Shortness of breathb Sleep disturbancec Daily activities disturbanced 
Age groups (years) OR (95% CI)  OR (95% CI)  OR (95% CI)  OR (95% CI)  
1 1.0 (0.9-1.2)  0.4 (0.2-0.5)  1.4 (1.1-1.7)  0.7 (0.6-0.9)  
2 1.0 (0.8-1.2)  0.6 (0.4-0.9)  1.1 (0.9-1.4)  0.8 (0.6-1.0)  
3-4 1.2 (1.0-1.5)  1.0 (0.7-1.6)  1.1 (0.9-1.5)  1.1 (0.8-1.3)  
5-6 (reference) 1.0   1.0   1.0   1.0  
7-9 1.3 (1.1-1.7)  1.1 (0.7-1.6)  0.9 (0.7-1.2)  1.0 (0.7-1.3)  
10-13 0.8 (0.6-1.1)  1.2 (0.8-1.9)  0.6 (0.4-0.9)  0.7 (0.5-1.0)  
14-17 0.8 (0.6-1.0)  1.7 (1.2-2.6)  0.5 (0.3-0.7)  0.6 (0.4-0.9)  
*Age-related change: test for the significance of change in prevalence with age for each of the symptoms, calculated with GEE and presented as odds ratio of change in 
prevalence per age group with respective p-values, accounting for repeated nature of measurements and clustered data. Baseline group: 5-6-year-old children.  
All symptoms refer to the past 12 months. 
a Frequent wheeze (≥4 wheeze attacks in past 12 months) 
b Wheeze always causing shortness of breath 
c Sleep disturbed due to wheeze (>1/week) 
d At least moderate disturbance of daily activities due to wheeze 
OR, odds ratio (GEE, generalised estimating equations, analysis) 
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Table E8—Unweighted and weighted prevalence of wheeze, episodic viral and multiple trigger wheeze, wheeze with different triggers, and indicators 
of severe wheeze in the entire cohort of children (absolute prevalence) 
Age group 
1-year-olds  
(N=4,102) 
2-year-olds  
(N=3,163) 
3-4-year-olds  
(N=4,071) 
5-6-year-olds 
(N=4,031) 
7-9-year-olds 
(N=3,244) 
10-13-year-olds 
(N=2,204) 
14-17-year-olds 
(N=2,025) 
 %(CI) %(CI) %(CI) %(CI) %(CI) %(CI) %(CI) 
Wheeze                         35.8(34.3-37.3) 24.0(22.5-25.5) 20.1(18.9-21.3) 16.9(15.8-18.1) 14.5(13.2-15.7) 16.6(15.0-18.1) 16.7(15.1-18.4) 
Weighted: 37.1(35.5-38.7) 25.0(23.3-26.6) 20.4(19.0-21.8) 18.2(16.6-19.9) 15.4(13.5-17.4) 16.1(13.9-18.3) 18.5(16.3-20.8) 
Episodic viral wheeze 23.8(22.5-25.2) 15.8(14.5-17.1) 11.2(10.2-12.2) 9.0(8.1-9.9) 5.4(4.6-6.2) 6.4(5.4-7.5) 6.5(5.3-7.7) 
                        Weighted: 24.3(22.9-25.7) 16.1(14.8-17.5) 11.2(10.1-12.3) 9.2(8.1-10.4) 6.0(4.7-7.3) 6.1(4.7-7.5) 7.1(5.5-8.6) 
Multiple trigger wheeze 11.5(10.5-12.4) 7.6(6.6-8.5) 8.0(7.2-8.9) 7.5(6.8-8.4) 8.5(7.5-9.5) 9.6(8.4-10.9) 9.7(8.3-11.0) 
            Weighted: 12.2(11.1-13.3) 8.1(7.1-9.2) 8.3(7.3-9.3) 8.5(7.2-9.8) 9.0(7.4-10.5) 9.7(8.0-11.5) 11.1(9.2-13.1) 
Wheeze, triggered by:        
Exercise 8.6(7.7-9.4) 8.2(7.2-9.2) 7.9(7.0-8.7) 7.8(6.9-8.6) 8.5(7.5-9.4) 11.0(9.7-12.3) 12.9(11.5-14.4) 
Weighted: 9.4(8.4-10.4) 8.6(7.6-9.7) 8.3(7.3-9.3) 9.2(7.8-10.6) 9.7(8.0-11.5) 11.1(9.2-13.0) 14.7(12.6-16.8) 
Aeroallergens 2.0(1.6-2.5) 2.5(1.9-3.0) 5.2(4.5-5.9) 6.0(5.3-6.8) 7.0(6.1-7.8) 9.5(8.3-10.8) 9.5(8.2-10.8) 
Weighted: 2.2(1.7-2.7) 2.7(2.0-3.3) 5.4(4.6-6.2) 7.5(6.1-8.8) 7.5(5.9-9.1) 9.4(7.6-11.1) 10.6(8.8-12.4) 
Food/drinks 2.7(2.2-3.2) 1.6(1.2-2.1) 1.3(1.0-1.7) 1.5(1.1-1.9) 1.6(1.2-2.0) 1.7(1.2-2.3) 1.3(0.8-1.8) 
Weighted: 3.0(2.4-3.6) 1.5(1.0-2.0) 1.6(1.1-2.1) 1.7(1.2-2.2) 1.6(1.1-2.1) 1.8(0.9-2.6) 1.4(0.6-2.2) 
Laughing/crying 10.3(9.3-11.3) 5.7(4.9-6.6) 3.1(2.6-3.7) 3.7(3.1-4.3) 2.5(2.0-3.1) 4.8(3.9-5.7) 6.0(4.9-7.0) 
Weighted: 11.1(10.0-12.1) 6.2(5.2-7.2) 3.7(2.9-4.5) 4.7(3.6-5.9) 3.1(2.2-4.0) 5.5(4.0-6.9) 6.3(5.0-7.7) 
Indicators of severe wheeze      
Frequent wheezea 12.5(11.5-13.6) 8.4(7.4-9.4) 8.1(7.2-8.9) 6.4(5.6-7.2) 6.6(5.7-7.4) 5.4(4.4-6.3) 5.3(4.3-6.3) 
Weighted: 13.3(12.2-14.4) 8.8(7.7-9.9) 8.0(7.1-9.0) 7.4(6.1-8.6) 7.0(5.5-8.5) 6.0(4.5-7.4) 6.1(4.6-7.7) 
Shortness of breathb  2.4(1.9-2.9) 2.5(1.9-3.0) 3.6(2.8-4.3) 2.9(2.1-3.8) 2.8(2.2-3.4) 3.5(2.7-4.3) 4.5(3.5-5.4) 
Weighted: 2.5(1.9-3.0) 2.6(2.0-3.2) 3.6(2.7-4.4) 2.9(2.0-3.8) 2.5(1.9-3.2) 3.6(2.5-4.7) 4.7(3.5-6.0) 
Sleep disturbancec 8.6(7.8-9.5) 5.0(4.3-5.8) 4.4(3.8-5.1) 3.6(3.0-4.2) 2.8(2.2-3.4) 2.2(1.5-2.8) 1.9(1.3-2.5) 
Weighted: 9.3(8.3-10.2) 5.5(4.7-6.4) 4.8(4.0-5.6) 5.0(3.8-6.2) 3.0(2.0-4.1) 2.5(1.5-3.5) 2.1(1.3-2.9) 
Daily activities disturbanced 4.6(4.0-5.3) 3.4(2.8-4.0) 4.0(3.4-4.6) 3.5(3.0-4.1) 3.0(2.4-3.6) 2.3(1.7-3.0) 2.0(1.4-2.6) 
Weighted: 4.9(4.2-5.7) 3.8(3.1-4.6) 4.2(3.5-4.9) 4.5(3.4-5.5) 3.0(2.0-4.0) 3.2(1.9-4.4) 2.7(1.7-3.7) 
a Frequent wheeze (≥4 wheeze attacks in past 12 months) 
b Wheeze always causing shortness of breath 
c Sleep disturbed due to wheeze (>1/week) 
d At least moderate disturbance of daily activities due to wheeze 
All wheezing characteristics refer to the past 12 months. 
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Table E9—Unweighted and weighted prevalence of wheeze, episodic viral and multiple trigger wheeze, wheeze with different triggers, and indicators 
of severe wheeze among children with any current wheeze (relative prevalence) 
Age group 
1-year-olds  
(Ncw=1447) 
2-year-olds  
(Ncw=744) 
3-4-year-olds  
(Ncw=810) 
5-6-year-olds  
(Ncw=675) 
7-9-year-olds  
(Ncw=465) 
10-13-year-olds  
(Ncw=362) 
14-17-year-olds  
(Ncw=336) 
 %(CI) %(CI) %(CI) %(CI) %(CI) %(CI) %(CI) 
Episodic viral wheeze 67.5(65.1-70.0) 67.6(64.2-71.0) 58.2(54.7-61.7) 54.4(50.5-58.2) 38.7(34.2-43.2) 40.1(34.9-45.2) 40.0(34.5-45.5) 
Weighted: 66.6(63.9-69.1) 66.5(62.7-70.1) 57.5(53.5-61.4) 52.1(46.9-57.3) 40.0(33.0-46.9) 38.5(31.2-45.7) 38.9(31.8-45.9) 
Multiple trigger wheeze 32.5(30.0-34.9) 32.4(29.0-35.8) 41.8(38.3-45.3) 45.6(41.8-49.5) 60.9(56.3-65.4) 59.9(54.8-65.1) 60.0(54.5-65.5) 
Weighted: 33.4(30.9-36.1) 33.5(29.9-37.3) 42.5(38.5-46.4) 47.9(42.7-53.0) 59.7(52.7-66.7) 61.5(54.3-68.8) 61.1(54.1-68.2) 
Wheeze, triggered by:        
Exercise 25.9(23.5-28.3) 37.6(33.8-41.3) 43.8(40.2-47.7) 50.4(46.4-54.4) 62.1(57.5-66.7) 66.5(61.6-71.4) 77.5(73.0-82.0) 
Weighted: 27.5(24.9-30.1) 38.0(34.1-41.9) 45.2(41.0-49.3) 54.6(49.3-59.9) 66.0(59.7-72.2) 69.0(62.4-75.7) 79.0(73.6-84.5) 
Aeroallergens 6.2(4.9-7.6) 11.8(9.3-14.3) 30.2(26.7-33.7) 39.0(35.1-42.9) 51.8(49.1-58.9) 58.4(53.2-63.6) 57.7(52.3-63.0) 
Weighted: 6.7(5.2-8.2) 12.1(9.4-14.8) 30.7(26.8-34.6) 44.4(38.9-50.0) 51.7(44.4-59.0) 59.0(51.7-66.2) 57.7(50.7-64.7) 
Food/drinks 8.2(6.7-9.7) 7.7(5.6-9.7) 8.0(5.9-10.1) 10.2(7.7-12.7) 12.6(9.4-15.9) 11.1(7.8-14.5) 8.1(5.1-11.1) 
Weighted: 8.9(7.2-10.6) 6.9(4.8-9.1) 9.3(6.5-12.0) 10.6(7.5-13.8) 12.3(8.4-16.1) 12.0(6.7-17.3) 8.0(3.8-12.2) 
Laughing/crying 34.0(31.3-36.8) 32.5(28.4-36.6) 32.6(27.6-37.5) 35.4(30.6-40.2) 30.4(24.7-36.1) 30.8(25.8-35.8) 36.6(31.4-41.9) 
Weighted: 35.3(32.4-38.2) 33.2(28.8-37.6) 34.8(28.8-40.7) 39.7(32.4-47.0) 34.9(26.8-43.0) 36.6(29.0-44.2) 35.1(28.5-41.6) 
Indicators of severe wheeze      
Frequent wheezea 35.1(32.6-37.6) 35.4(31.9-38.9) 39.8(36.4-43.1) 37.2(33.6-40.9) 45.0(40.5-49.6) 32.1(27.3-37.0) 31.6(26.6-36.6) 
Weighted: 35.9(33.3-38.5) 35.7(32.0-39.3) 38.7(35.0-42.5) 40.0(34.7-45.1) 44.7(37.7-51.6) 36.3(29.2-43.5) 33.0(26.1-39.9) 
Shortness of breathb  6.7(5.4-8.0) 10.4(8.2-12.6) 17.2(13.7-20.8) 17.4(12.9-21.9) 18.6(15.0-22.3) 20.5(16.3-24.7) 25.9(21.2-30.7) 
Weighted: 6.7(5.3-8.0) 10.4(8.1-12.8) 17.1(13.4-20.8) 17.1(12.1-22.1) 15.9(11.7-20.1) 21.7(15.7-27.7) 24.9(19.0-30.8) 
Sleep disturbancec 24.3(22.1-26.6) 21.1(18.2-25.6) 21.8(19.0-24.7) 21.1(18.0-24.3) 19.0(15.4-22.6) 13.0(9.5-16.5) 10.9(7.5-14.2) 
Weighted: 25.2(22.8-27.6) 22.4(19.2-25.8) 23.1(19.7-26.5) 27.2(21.9-32.6) 19.5(13.6-25.4) 15.3(9.8-20.9) 11.1(7.2-15.0) 
Daily activities disturbanced 12.9(11.2-14.7) 14.2(11.7-16.8) 19.5(16.7-22.3) 19.9(16.8-22.9) 19.7(16.1-23.3) 13.9(10.3-17.5) 12.0(8.4-15.5) 
Weighted: 13.4(11.5-15.3) 15.4(12.7-18.2) 20.1(16.9-23.3) 23.8(18.9-28.7) 18.6(13.0-24.2) 19.0(12.2-25.7) 14.4(9.5-19.3) 
a Frequent wheeze (≥4 wheeze attacks in past 12 months) 
b Wheeze always causing shortness of breath 
c Sleep disturbed due to wheeze (>1/week) 
d At least moderate disturbance of daily activities due to wheeze  
All wheezing characteristics refer to the past 12 months. 
%(CI), unweighted prevalence with confidence intervals; Ncw, number of children with current wheeze at respective age 
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Table E10—Comparison of parent-reported to self-reported symptoms:  
Sensitivity analysis in the 2010 survey (1,821 children aged 14-17 years) in entire cohort 
Symptom Parent-reported (n=749) Self-reported (n=1,072) 
 
 
  % (CI) % (CI) p-value
a
 
Wheeze                         12.3 (9.8-15.4) 17.3 (14.9-20.0) 0.012 
Episodic viral wheeze 5.2 (3.6-7.4) 6.2 (4.8-8.1) 0.415 
Multiple trigger wheeze 6.1 (4.3-8.5) 10.6 (8.6-12.9) 0.005 
    
Wheeze, triggered by:    
Exercise 8.0 (6.0-10.7) 14.4 (12.2-16.9) <0.001 
Aeroallergens 8.0 (6.0-10.7) 8.9 (7.2-11.0) 0.570 
Food/drinks 0.9 (0.4-2.2) 1.5 (0.9-2.5) 0.375 
Laughing/crying 2.2 (1.3-3.9) 7.6 (6.0-9.6) <0.001 
    
Indicators of severe wheeze   
Frequent wheezeb 4.0 (2.6-6.0) 4.8 (3.6-6.5) 0.437 
Shortness of breathc  3.5 (2.2-5.5) 4.1 (2.9-5.6) 0.617 
Sleep disturbance
d
 1.5 (0.8-3.0) 1.8 (1.1-3.0) 0.651 
Daily activities disturbance
e
 1.9 (1.0-3.5) 2.0 (1.2-3.2) 0.924 
    
a Difference between parent- and self-reported symptoms calculated with unpaired (two-sample) t-test 
b Frequent wheeze (≥4 wheeze attacks in past 12 months) 
c Wheeze always causing shortness of breath 
d Sleep disturbed due to wheeze (>1/week) 
e At least moderate disturbance of daily activities due to wheeze 
All wheezing characteristics refer to the past 12 months.   
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Fig. 1. Absolute prevalence of wheeze, triggered by different factors, and of different 
indicators of wheeze severity in entire cohort of children from age 1 to 17 years. 
Prevalence presented as proportion (in %) with 95% confidence intervals.  
 
 
Fig. 2. Prevalence of episodic viral wheeze and of multiple trigger wheeze in the entire 
cohort (absolute prevalence) and among children with current wheeze (relative 
prevalence, from age 1 to 17 years. Prevalence is presented as proportion (in %) with 95% 
confidence intervals.   
 
 
Fig. 3. Relative prevalence of wheeze, triggered by different factors, and of different 
indicators of wheeze severity among children with current wheeze from age 1 to 17 
years. Prevalence presented as proportion (in %) with 95% confidence intervals.  
 
 
 
 
 
Fig. E1. Age of the children of the Leicester Respiratory Cohorts participating in the 
respective surveys; The bands on the x-axis show the seven age groups used for the analysis 
(1, 2, 3-4, 5-6, 7-9, 10-13, and 14-17 year-olds). The y-axis shows the years when surveys 
were conducted. In 1999, only those who responded in 1998 and were born in years 1996-7 
(age 1 at the first survey) were included. 
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